| KPI | [EUR m] | Q1 2023 | FY 2023 | Q1 2024 E | FY 2024 E | FY 2025 E | FY 2026 E | FY 2027 E | FY 2028 E |
|---|---|---|---|---|---|---|---|---|---|
| Net sales, Biopharma | Number of Estimates | 15 | 15 | 15 | 15 | 15 | 15 | ||
| Net sales, Biopharma | Highest | 9,036 | 40,366 | 43,993 | 47,122 | 50,611 | 54,280 | ||
| Net sales, Biopharma | Consensus (Mean) | 8,727 | 37,890 | 8,748 | 39,803 | 42,834 | 45,866 | 48,669 | 51,349 |
| Net sales, Biopharma | Lowest | 8,556 | 39,155 | 41,857 | 44,486 | 47,031 | 48,294 | ||
| Business operating income (Biopharma) | Number of Estimates | 10 | 10 | 10 | 10 | 10 | 10 | ||
| Business operating income (Biopharma) | Highest | 2,527 | 11,185 | 13,207 | 14,697 | 15,913 | 17,724 | ||
| Business operating income (Biopharma) | Consensus (Mean) | 2,789 | 11,247 | 2,301 | 10,909 | 12,535 | 13,710 | 14,851 | 16,031 |
| Business operating income (Biopharma) | Lowest | 2,127 | 10,526 | 11,859 | 12,667 | 13,443 | 14,182 | ||
| - as % of net sales (Biopharma operating margin) | Number of Estimates | 10 | 10 | 10 | 10 | 10 | 10 | ||
| - as % of net sales (Biopharma operating margin) | Highest | 28.0 | 28.0 | 30.6 | 31.4 | 31.4 | 32.7 | ||
| - as % of net sales (Biopharma operating margin) | Consensus (Mean) | 32.0 | 29.7 | 26.3 | 27.4 | 29.1 | 29.7 | 30.3 | 31.1 |
| - as % of net sales (Biopharma operating margin) | Lowest | 24.9 | 26.6 | 27.6 | 27.9 | 28.5 | 29.0 | ||
| Consumer Healthcare | Number of Estimates | 15 | 15 | 15 | 15 | 15 | 15 | ||
| Consumer Healthcare | Highest | 1,584 | 5,609 | 5,883 | 6,232 | 6,679 | 7,263 | ||
| Consumer Healthcare | Consensus (Mean) | 1,495 | 5,180 | 1,511 | 5,385 | 5,600 | 5,843 | 6,087 | 6,328 |
| Consumer Healthcare | Lowest | 1,429 | 5,139 | 5,282 | 5,436 | 5,595 | 5,759 | ||
| Business operating income (Consumer Healthcare) | Number of Estimates | 10 | 10 | 10 | 10 | 10 | 10 | ||
| Business operating income (Consumer Healthcare) | Highest | 528 | 1,571 | 1,636 | 1,775 | 2,036 | 2,370 | ||
| Business operating income (Consumer Healthcare) | Consensus (Mean) | 534 | 1,438 | 478 | 1,463 | 1,559 | 1,659 | 1,751 | 1,847 |
| Business operating income (Consumer Healthcare) | Lowest | 385 | 1,317 | 1,400 | 1,486 | 1,568 | 1,655 | ||
| - as % of net sales (Consumer Healthcare operating margin) | Number of Estimates | 10 | 10 | 10 | 10 | 10 | 10 | ||
| - as % of net sales (Consumer Healthcare operating margin) | Highest | 34.9 | 29.0 | 29.0 | 29.6 | 30.5 | 32.6 | ||
| - as % of net sales (Consumer Healthcare operating margin) | Consensus (Mean) | 35.7 | 27.8 | 31.5 | 27.1 | 27.8 | 28.3 | 28.7 | 29.0 |
| - as % of net sales (Consumer Healthcare operating margin) | Lowest | 25.3 | 24.1 | 24.5 | 24.9 | 25.2 | 25.5 | ||
| Other Business operating income | Number of Estimates | 9 | 9 | 9 | 9 | 9 | 9 | ||
| Other Business operating income | Highest | 13 | 3 | 3 | 29 | 29 | 29 | ||
| Other Business operating income | Consensus (Mean) | 10 | -15 | 2 | -16 | -17 | -11 | -11 | -11 |
| Other Business operating income | Lowest | -22 | -81 | -83 | -84 | -86 | -88 |
This document has been issued by Vara Research GmbH for information purposes only and is not intended to constitute investment advice. It is based on estimates and forecasts of various analysts regarding revenues, earnings and business developments of the relevant company. The company did not participate in the compilation of the estimates and it does not endorse them. Such estimates and forecasts cannot be independently verified by reason of the subjective character. Vara Research GmbH gives no guarantee, representation or warranty and is not responsible or liable as to its accuracy and completeness.
